The above findings on the inhibitory effect of obestatin on IL-1β levels, and MPO activity in colonic mucosa in rats with TNBS-induced colitis indicated that the effect of promoting healing was at least, in part, associated with the anti-inflammatory properties of obestatin. Here, IL1B is linked to colitis.